Canada markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.9700+0.3600 (+13.79%)
At close: 04:00PM EDT
3.0000 +0.03 (+1.01%)
After hours: 05:38PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 6.50M
Enterprise Value 1.14M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.68
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.05

Trading Information

Stock Price History

Beta (5Y Monthly) 1.29
52-Week Change 3-81.24%
S&P500 52-Week Change 323.06%
52 Week High 321.2500
52 Week Low 32.5100
50-Day Moving Average 36.1832
200-Day Moving Average 37.5555

Share Statistics

Avg Vol (3 month) 331.26k
Avg Vol (10 day) 326.35k
Shares Outstanding 52.52M
Implied Shares Outstanding 62.52M
Float 82.23M
% Held by Insiders 14.71%
% Held by Institutions 115.11%
Shares Short (Mar 28, 2024) 486.6k
Short Ratio (Mar 28, 2024) 41.93
Short % of Float (Mar 28, 2024) 43.55%
Short % of Shares Outstanding (Mar 28, 2024) 43.44%
Shares Short (prior month Feb 29, 2024) 418.08k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Dec 19, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,695.88%

Management Effectiveness

Return on Assets (ttm)-75.71%
Return on Equity (ttm)-130.94%

Income Statement

Revenue (ttm)733.87k
Revenue Per Share (ttm)0.41
Quarterly Revenue Growth (yoy)-63.40%
Gross Profit (ttm)N/A
EBITDA -21.39M
Net Income Avi to Common (ttm)-21.24M
Diluted EPS (ttm)-11.8500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.48M
Total Cash Per Share (mrq)2.17
Total Debt (mrq)115.25k
Total Debt/Equity (mrq)1.21%
Current Ratio (mrq)3.12
Book Value Per Share (mrq)4.04

Cash Flow Statement

Operating Cash Flow (ttm)-16.04M
Levered Free Cash Flow (ttm)-8.75M